Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

Human adenoviruses (HAdV) are ubiquitous human pathogens that cause a significant burden of respiratory, ocular, and gastrointestinal illnesses. Although HAdV infections are generally self-limiting, pediatric and immunocompromised individuals are at particular risk for developing severe disease. Currently, no approved antiviral therapies specific to HAdV exist. Recent outbreaks underscore the need for effective antiviral agents to treat life-threatening infections. In this review we will focus on recent developments in search of potential therapeutic agents for controlling HAdV infections, with a focus on those targeting post-entry stages of the virus replicative cycle. Copyright © 2021 Elsevier B.V. All rights reserved.


Mackenzie J Dodge, Katelyn M MacNeil, Tanner M Tessier, Jason B Weinberg, Joe S Mymryk. Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies. Antiviral research. 2021 Apr;188:105034

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 33577808

View Full Text